MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026 https://www.businesswire.com/news/h...-with-Three-Phase-3-Readouts-Expected-in-2026
GO TO THIS URL: https://ir.definiumtx.com/news-even...-44th-annual-j-p-morgan-healthcare-conference Click the Webcast Link at 5:15pm EST
Definium defines mental health applications for LSD in new awareness campaign https://www.fiercepharma.com/market...zempic-push-starring-justin-long-john-hodgman
PATENT GRANTED - $DFTX Immediate release formulations of d-lysergic acid diethylamide for therapeutic applications https://ppubs.uspto.gov/api/patents...4LTRlZWQtYTBiOC0yYjdjZjJhZWMwNDAiLCJleHAiOjB9
Reminder All Older Posts prior to company name change can be found here: https://stockaholics.net/threads/mnmd-mindmed-inc.12024/
Definium Therapeutics stock price target raised to $36 from $20 at RBC Capital $DFTX www.investing.com/news/analyst-ratings/definium-therapeutics-stock-price-target-raised-to-36-from-20-at-rbc-capital-93CH-4462617
